Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Assays for HSP90 and inhibitors.

× No keyword cloud information.

8 in total

1. Biochemical and biophysical characterization of the Mg2+-induced 90-kDa heat shock protein oligomers.

Authors: Laura Moullintraffort; Matthieu Bruneaux; Alexis Nazabal; Diane Allegro; Emmanuel Giudice; Franck Zal; Vincent Peyrot; Pascale Barbier; Daniel Thomas; Cyrille Garnier
Journal: J Biol Chem Date: 2010-03-14 Impact factor: 5.157

Review 2. Progress in lanthanides as luminescent probes.

Authors: I Hemmilä; V Laitala
Journal: J Fluoresc Date: 2005-07 Impact factor: 2.217

3. Linker histones stimulate HSPA2 ATPase activity through NASP binding and inhibit CDC2/Cyclin B1 complex formation during meiosis in the mouse.

Authors: Oleg M Alekseev; Richard T Richardson; Michael G O'Rand
Journal: Biol Reprod Date: 2009-06-24 Impact factor: 4.285

4. Hsp90 (heat shock protein 90) inhibitor occupancy is a direct determinant of client protein degradation and tumor growth arrest in vivo.

Authors: Bonnie Tillotson; Kelly Slocum; John Coco; Nigel Whitebread; Brian Thomas; Kip A West; John MacDougall; Jie Ge; Janid A Ali; Vito J Palombella; Emmanuel Normant; Julian Adams; Christian C Fritz
Journal: J Biol Chem Date: 2010-10-12 Impact factor: 5.157

Assays for HSP90 and inhibitors.

1. Biochemical and biophysical characterization of the Mg2+-induced 90-kDa heat shock protein oligomers.

Review 2. Progress in lanthanides as luminescent probes.

3. Linker histones stimulate HSPA2 ATPase activity through NASP binding and inhibit CDC2/Cyclin B1 complex formation during meiosis in the mouse.

4. Hsp90 (heat shock protein 90) inhibitor occupancy is a direct determinant of client protein degradation and tumor growth arrest in vivo.

5. Depletion of the histone chaperone tNASP inhibits proliferation and induces apoptosis in prostate cancer PC-3 cells.

Review 6. Assay design and development strategies for finding Hsp90 inhibitors and their role in human diseases.

Review 7. Review: The HSP90 molecular chaperone-an enigmatic ATPase.

Review 8. Hsp90 Inhibitors for the Treatment of Chronic Myeloid Leukemia.